Fibroblast growth factor-1 (FGF1) is one of the most potent angiogenic growth factors, and also plays an important role in regulating cellular functions including cell proliferation, motility, differentiation, survival, and tissue regeneration processes. Here we described a novel fusion protein that was designed by combining the cell adhesion sequence from fibronectin with FGF1. The F1-Fn fusion protein functions as a minimized protein that directs integrin-dependent cell adhesion and stimulates cellular responses including cell proliferation and differentiation. Moreover, our results indicate that Fn-mediated signaling synergizes with signals from FGF1 in promoting cellular adhesion, proliferation, and differentiation in MG63 cells.
Introduction
A successful tissue repair including wound healing depends upon angiogenesis. Immediately following injury, angiogenesis is initiated by multiple molecular signals, including hemostatic factors, inflammation, cytokine growth factors, and cell-matrix interactions. Fibroblast growth factor-1 (FGF1) is one of the most potent angiogenic growth factors, and also plays an important role in regulating cellular functions including cell proliferation, motility, differentiation, survival, and tissue regeneration processes [1] .
Cells also need to adhere specifically to extracellular matrix (ECM) components of their environment to carry out diverse physiological functions including development, organization, and maintenance of issues [2] . The critical importance of ECM ligands, adhesion receptors, and signaling interactions is underscored by the absolute lethality at early embryonic development in models with targeted gene deletions [3, 4] . Thus, cell adhesion to ECM ligands is crucial to numerous biotechnological and biomedical applications, including biomaterials, artificial organs, tissue engineering, and synthetic supports for in vitro cell culture. An ideal ECM-mimetic tissue engineering scaffold should contain both adhesion proteins and growth factors.
Fibronectin (Fn) is a major ECM component used by many cell types as a substrate for attachment [5] . It is composed of homologous repeats of three prototypical types of homologous repeating modules known as types I, II, and III, which are organized into functional domains. FN mediates its biological effects through binding to the hetero-dimeric transmembrane glycoproteins, or integrins, which physically couple the cytoskeleton to the ECM. FN binds to the integrin through a consensus site including the Arg-Gly-Asp sequence within tenth type III module [6] . A short sequence Pro-His-Ser-Arg-Asn has also been identified as a synergistic motif within ninth type III module for binding to a5b1 integrin [7] . Through these interactions, integrins play a critical role in the regulation of a number of cellular functions, such as adhesion, migration, cytoskeletal reorganizations, and signal transduction responses including tyrosine phosphorylation of cytoplasmic molecules and activation of mitogen-activated protein kinase (MAPK) family [8, 9] .
In this study, we developed a novel therapeutic protein for tissue regeneration by engineering of a fusion protein containing Fn fragment connected to the C-terminus of FGF1.
Material and Methods
Construction of expression plasmids and fusion protein purification PCR primers were designed to recognize FGF1: forward 'FGF1-BF' primer, 5 0 -GAAGATCTGCTGAAGGGGAA-ATC-3 0 ; and reverse 'FGF1-KR' primer, 5 0 -GGGGTAC-CATCAGAAGAGACTGG-3 0 . PCR was performed in a 50-ml reaction containing 50 mM MgCl 2 , 100 mg/ml gelatin, 0.2 mM dNTPs, 1.25 U of Taq polymerase (Perkin-Elmer, Waltham, USA), and 50 pmol each of the forward and reverse primers. The thermo cycling parameters used in PCR were as follows: annealing, 1 min at 558C; extension, 2 min at 728C; denaturation, 1 min at 948C. After 30 cycles, amplified cDNAs were digested with BglII and KpnI. After digestion, PCR products were in frame ligated into the multiple cloning sites of pBAD/His-A-FnIII 9-10 [10] with the C-terminal His 6 tag. The F1-Fn fusion proteins with His 6 tag were expressed and purified using a Ni 2þ affinity column under denaturing conditions according to the manufacturer's protocol (Invitrogen, Carlsbad, USA).
Cell culture
The MG63 cells (KCLB) derived from an osteosarcoma were used in this study. The culture medium used was Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% (v/v) fetal calf serum (Invitrogen) and antibiotic/antimycotic (100 U/ml penicillin G sodium, 100 mg/ml streptomycin, and 0.25 mg/ml amphotericin B) in a 5% (v/v) CO 2 incubator. MG63 cells were trypsinized using 0.1% (v/v) ethylenediaminenitroacetic acid for 5 min, centrifuged at 400 g for 5 min, and resuspended in the medium.
Cell adhesion assay MG63 cells were serum starved for 24 h, harvested in 0.02% (w/v) trypsin and 1 mM EDTA, resuspended in DMEM, washed three times with DMEM containing 100 mg/ml soybean trypsin inhibitor and 1% (w/v) BSA, and plated at 5 Â 10 4 cells per well in DMEM. Twenty-four well plates were coated with either Fn or F1-Fn overnight at 48C at the indicated concentrations, then blocked with 1% (w/v) BSA in PBS for 30 min, and rinsed with PBS. Non-specific adherence was blocked by incubation with 0.5% BSA in PBS for 1 h at 378C. Suspensions of control cells were maintained in BSA-coated plates for indicated time. After 30 min at 378C, adherent cells were washed twice with PBS, fixed with 3% (w/v) paraformaldehyde (Sigma, St. Louis, USA), stained with 0.25% (w/v) crystal violet (Sigma) in 2% (v/v) ethanol/water. The plates were allowed to dry. The absorbance was read at measured at 570 nm and non-specific adhesion was determined in wells coated with 1% (w/v) BSA as negative control.
Proliferation assay (MTS assay)
Proliferation was assessed by the MTS tetrazolium assay (Celltiter96 TM AQ non-radioactive cell proliferation assay; Promega, Madison, USA), which measures the number of viable cells as described by the manufacturer. This assay measures the conversion of 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) into aqueous soluble formazan product that absorbs at 490 nm. The MG63 cells were seeded on 24-well culture dishes coated with 10 ng/ml of recombinant proteins at 10 4 cells per well. Two hours after adding MTS (40 ml), the plates were read at 490 nm.
RT -PCR analysis
The cells were plated at a density of 5 Â 10 5 cells/ml. Total cellular RNA was isolated using RNeazy kit according to the directions of the manufacturer (Qiagen, Chatsworth, USA). The first-strand synthesis of singlestrand cDNA from RNA for use as a PCR template was carried out with Superscript TM first-strand cDNA synthesis kit (Invitrogen). The PCR was carried out in 10 mM Tris-HCl ( pH 8.3), 50 mM KCl, 1.5 mM MgCl 2 , 0.2 mM dNTPs, and 0.5 U of Taq polymerase in 12.5 ml of final volume with 1 ml cDNA and 0.5 mM each of primers. The amplifications were performed in a GeneAmp PCR system 9600 (Perkin-Elmer). The reaction profile consisted of one cycle at 948C for 1 min, followed by 25 cycles at 948C for 30 s, 588C for 30 s, and 728C for 1 min. The PCR products were then resolved on 1.5% ethidium bromide-stained agarose gel. Primers set for PCR were as follows: 0 for GAPDH as a control.
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Western blot analysis Activation of MAPK (ERK, JNK, and p38 MAPK) was determined by using anti-phosphotyrosine antibody (Santa Cruz Biotechnology, Santa Cruz, USA) (1:1000). Proteins binding to the primary antibodies were detected with a horseradish peroxidase-conjugated secondary anti-rabbit antibody (Santa Cruz Biotechnology) (1:1000) and visualized by enhanced chemiluminescence (ECL) system (Amersham Life Science, San Francisco, USA). Antibody binding was detected using ECL system and Hyperfilm X-ray film.
Statistical analysis
Experiments were repeated three to five times. Data were expressed as the mean+standard deviation (SD). Data were analyzed using one-way analysis of variance (ANOVA) with Tukey's Multiple Comparison Test to a confidence level of P , 0.05.
Results

Expression and purification of the recombinant fusion protein in Escherichia coli
To link Fn fragment with FGF1, the minimal integrin-binding segment making up the 9th and 10th type III domains of Fn was fused with FGF1, designated F1-Fn. The cDNA encoding FGF1 was subcloned into a pBAD/His-A-FnIII 9-10 expression vector at the BglII and KpnI restriction sites for bacterial expression as described above. This vector contains an araBAD promoter for tightly regulated expression and an N-terminal polyhistidine sequence for affinity purification. For expression of recombinant F1-Fn, E. coli TOP10 cells were grown overnight in LB-Amp medium at 378C. When the cultures reached an A 600 value of 0.5, protein expression was initiated with 0.02% (w/v) L-arabinose as inducer. After 3 h, cells were harvested by centrifugation, lysed, and sonicated. A soluble extract was prepared by centrifugation at 14,000 g for 30 min. The crude protein from the cell extract was purified through binding of the His 6 tag (located at the N-terminal end of the protein) to the nickel-nitrilotriacetic acid resin column. The degree of purification of the recombinant protein was examined under denaturing conditions as determined by Coomassie blue staining of 10% SDS-PAGE. Upon induction with L-arabinose, E. coli TOPl0 produced a protein of molecular weight of about 50 kDa (estimated by SDS-PAGE), the size expected for a fusion protein consisting of Fl-Fn and the N-terminal His 6 tag (Fig. 1) .
Synergistic effect of F1-Fn fusion protein on human osteoblast-like MG63 cells adhesion and spreading
To analyze the ability of F1-Fn fusion protein to enhance cell adhesion, human osteoblast-like MG63 cells were resuspended in serum-free medium and then seeded in plastic tissue-culture dishes coated with F1-Fn. Figure 2 showed examples of cell adhesion for F1-Fn, Fn, and FGF1 (F1) (10 ng/ml). We found that the F1-Fn fusion protein increased MG63 cells adhesion by approximately 2 folds compared with Fn (Fig. 2) . These results indicate that the F1-Fn fusion protein improves the adhesion of the MG63 cells.
Enhanced mitogenic activity of F1-Fn fusion protein MTS assay involves a conversion of an MTS into formazan product when incubated with viable cells. Thus the 
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absorbance of formazan indirectly reflected the level of cellular proliferation. Figure 3 showed that the absorbance of formazan produced by cells on the F1-Fn is significantly higher when compared with those of Fn-coated dishes after 3 days of culture (P , 0.05).
Increased osteoblastic differentiation on F1-Fn fusion protein Next, we further examined the effect of the F1-Fn fusion protein on the osteoblastic differentiation using the MG63 cells. The expression of ALP mRNA was increased when the MG63 cells were cultured on the Fl -Fn fusion protein (Fig. 4) . A high expression of ALP mRNA in cells grown on the F1-Fn fusion protein was prominent at 3 days of culture. An ability of the F1-Fn fusion protein to enhance osteoblastic differentiation was further analyzed by examining other osteoblastic differentiation-associated genes such as OPN. The expression of OPN in the MG63 cultured on F1-Fn fusion protein was also increased by the F1-Fn fusion protein treatment (Fig. 4) . ALP is the most widely recognized marker of osteoblastic differentiation [11] . Thus, the expression of these genes is indicative of osteoblastic differentiation of MG63 cells.
Activation of ERK signaling pathway as molecular mechanism for the F1 -Fn fusion protein Finally, we investigated the downstream signaling pathway responsible for the F1-Fn fusion protein in MG63 cells. The MAPK signaling cascade has been implicated in the regulation of numerous cellular processes including cell growth and differentiation, and it can be activated by integrin. To further investigate whether MAPK (ERK, JNK, and p38 MAPK) cascade is involved in F1-Fn-mediated signaling, we examined the phosphorylated forms of ERK, JNK, and p38 using phosphor-specific antibodies. The phosphorylation of ERK increased significantly after MG63 cells being attached on F1-Fn fusion protein (Fig. 5) . Thus, F1-Fn-mediated signaling is capable of activating ERK-type MAPK pathway in MG63 cells.
Discussion
In this study, we have investigated the effect of F1-Fn fusion protein on cellular proliferation, cellular adhesion, cellular morphology, and osteoblastic differentiation of , and F1 -Fn proteins (10 ng/ml) coated dishes for 0.5 h. ERK activation was measured by immunoblotting with a phospho-specific ERK antibody ( p-ERK1, p-ERK2). After stripping, blots were re-probed with anti-ERK1 antibody (t-ERK1, t-ERK2) to examine equal protein levels. Angiogenesis is a physiological process that is vital for normal wound healing. Clinically, new capillaries first become visible in the wound bed 325 days after injury, and their appearance is synonymous with granulation, the creation of a provisional matrix comprised of proliferating blood vessels, migrating fibroblasts and new collagen. FGF1 is a potent pleiotropic mitogen endowed with a potent angiogenic activity in vitro and in vivo [12, 13] . It acts synergistically with vascular endothelial growth factor to stimulate new vessel growth, which is required during tissue repair. To make it potent for clinical use, FGF1 sequence was inserted into Fn adhesion site using a gene fusion technique.
It is of interest that F1-Fn activated ERK signaling pathway in MG63 cells. ERK activation has been associated with proliferative responses and differentiation [14] . ERK activation is associated with translocation of ERKs to the nucleus, which leads to the modulation of molecule gene expressions. The synergistic activation of ERK upon the activation of F1-Fn indicated that MEK/MAPK pathway is engaged both with FGF1 and Fn signaling pathway for the synergistic effect of F1-Fn. Our results indicate that Fn-mediated signaling synergizes with signals from FGF1 in promoting cellular responses in MG63 cells. Here we describe a novel fusion protein that was designed by combining the cell adhesion sequence from Fn and FGF1. The F1-Fn fusion protein functions as a minimized protein that directs integrin-dependent cell adhesion and stimulates cellular responses including cell proliferation and differentiation.
In conclusion, our results provided evidences that the F1-Fn fusion protein could efficiently promote cellular adhesion, proliferation, and differentiation through ERK signaling pathway MG63 cells. These experiments have demonstrated that this fusion protein design may thus serve as a general route for improving a variety of bioactive sequences for applications in medical protein therapeutics, wound healing, and tissue regeneration. 
